RCLIX
Price
$47.08
Change
-$0.20 (-0.42%)
Updated
Jul 13 closing price
Net Assets
18.22B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

RCLIX vs VFFSX

RCLIX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
RCLIX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCLIX is a Buy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. RCLIX (18.2B). VFFSX pays higher dividends than RCLIX: VFFSX (1.08) vs RCLIX (0.53). RCLIX was incepted earlier than VFFSX: RCLIX (10 years) vs VFFSX (10 years). RCLIX (0.57) is less costly to investors than VFFSX (0.01). RCLIX is a more actively managed with annual turnover of: 65.40 vs. VFFSX (2.00). RCLIX has a lower initial minimum investment than VFFSX: RCLIX (500000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. RCLIX (9.50). VFFSX return over 5 years is better than : 73.48 vs. RCLIX (35.81).
RCLIXVFFSXRCLIX / VFFSX
Total Expense Ratio0.570.015,700%
Annual Report Gross Expense Ratio0.570.015,700%
Fund Existence10 years10 years-
Gain YTD9.97910.68593%
Front LoadN/AN/A-
Min. Initial Investment50000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets18.2B1.67T1%
Annual Yield % from dividends0.531.0849%
Returns for 1 year9.5021.0745%
Returns for 3 years46.5168.4568%
Returns for 5 years35.8173.4849%
Returns for 10 yearsN/A251.21-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6